Phep, an amino acid permease of staphylococcus aureus

Details for Australian Patent Application No. 2005238265 (hide)

Owner Absynth Biologics Ltd

Inventors Foster, Simon J.

Agent FB Rice

Pub. Number AU-B-2005238265

PCT Pub. Number WO2005/105845

Priority 0409559.2 29.04.04 GB

Filing date 8 April 2005

Wipo publication date 10 November 2005

Acceptance publication date 18 August 2011

International Classifications

C07K 14/195 (2006.01) Peptides having more than 20 amino acids - from bacteria

A61K 39/085 (2006.01) Medicinal preparations containing antigens or antibodies - Staphylococcus

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

9 November 2006 PCT application entered the National Phase

  PCT publication WO2005/105845 Priority application(s): WO2005/105845

19 April 2007 Assignment before Grant

  University of Sheffield The application has been assigned to Absynth Biologics Ltd

18 August 2011 Application Accepted

  Published as AU-B-2005238265

15 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005238270-Morpholinylanilinoquinazoline derivatives for use as antiviral agents

2005238241-Method for recovering gold